IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Preclinical biotech developing engineered T cell cancer therapies.
Industry: Health Care
Latest Trade: $7.03 +0.11 (+1.5%)
First Day Return: -30.0%
Return from IPO: -53.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/23/2021 |
Offer Price | $15.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 6.7 |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/15/2021 |
Offer Price | $15.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 6.7 |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2018 |
Employees | 61 |
Website www.tscan.com |